Delivery Order SPE2DB22D2206-SPE2DB25FGS91

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,397.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of Hydromorphone 1 mg/ml vials, a pain management medication. The contract has a completion date of September 14, 2022 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,472.10 firm fixed price delivery order is for the supply of hydromorphone 1 mg/ml carpujctml, a pain management medication. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,475.20, is a Firm Fixed Price Delivery Order for the supply of HYDROMORPHONE 500 MG/50 ML VL 50ML. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,303.20 firm fixed-price delivery order is for HYDROMORPHONE 500 MG/50 ML VL 50ML, a pharmaceutical product. The contract has a completion date of February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of hydromorphone 1 mg/ml vials. The $1,171.11 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,201.29, is for the delivery of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,304.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hydromorphone 1 mg/ml vials, a controlled substance used for pain management. The award is structured as a Firm Fixed Price Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $2,823.18 firm fixed-price delivery order is for the supply of Hydromorphone 1 mg/ml, a pain management medication. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
This federal contract award, valued at $1,003.80, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) and is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical program. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,010.11 firm fixed-price delivery order is for the supply of hydromorphone 1 mg/ml vial, a pain medication. The contract has an ultimate completion date of August 10, 2022 and was awarded on August 9, 2022. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGS91
    Delivery Order

This federal contract award, valued at $1,282.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hydromorphone 2 mg/ml, a pain management medication, with a performance period through April 2025.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard. The current award is not designated as a set-aside contract, indicating open competition.

Generated 7/25/25, 11:22 AM